Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?

SIMPLE SUMMARY: Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity accounting for ≈5% of all Hodgkin lymphoma (HL) cases. Since pathological characteristics and clinical presentation of NLPHL differ from classical HL and often resemble indolent B-cell non-Hodgkin lymph...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichenauer, Dennis A., Fuchs, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340679/
https://www.ncbi.nlm.nih.gov/pubmed/37444420
http://dx.doi.org/10.3390/cancers15133310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340679/
https://www.ncbi.nlm.nih.gov/pubmed/37444420
http://dx.doi.org/10.3390/cancers15133310

Ejemplares similares